# Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia

> **NCT00345033** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 38 (actual)

## Conditions studied

- Schizophrenia
- Insulin Resistance

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00345033
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2009-10
- **Final completion:** 2010-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345033, "Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00345033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*